☰

Bolsa, mercados y cotizaciones

Teva makes $82 per share offer for Mylan


    TEL AVIV/NEW YORK (Reuters) - Generic drugmaker Teva Pharmaceutical Industries Ltd. said on Tuesday that it had proposed buying rival Mylan for $82.00 per share in a mix of stock and cash.

    Teva said the offer was a 48-percent premium to the stock price of MYLAN (MYL.NQ)(MYL.NQ)on March 10, 2015, which it said was "the last day of trading prior to widespread speculation of a transaction between Teva and Mylan."

    (Reporting by Caroline Humer; Editing by Alden Bentley)